Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06746714 · ClinicalTrials.gov registry record · NA
Hypoglycemia Prevention in High-Risk Type 2 Diabetes Patients
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT06746714 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 200 participants.
The verdict
NCT06746714, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
Severe low blood sugar (hypoglycemia) is a serious problem for people with diabetes. It can lead to dangerous falls, heart problems, memory issues, and even death. However, many healthcare providers don't recognize or manage this problem well. The investigators believe that creating a clear set of guidelines for preventing hypoglycemia, along with having a clinical pharmacist actively help high-risk patients, can make diabetes treatment safer. In this study, the investigators developed a simple, evidence-based guide called "Hypoglycemia on a Page" (HOAP) to prevent low blood sugars. The investigators then tested it by comparing two groups of patients with type 2 diabetes who are at high risk for hypoglycemia. One group received active support from a clinical pharmacist using the HOAP guidelines, while the other group received standard care. The main goal of this study is to see if the pharmacist's support leads to safer diabetes treatment. The investigators will also look at other factors, such as whether patients are prescribed glucagon (a medicine for severe low blood sugar), if they use continuous glucose monitoring, and whether they have worse blood sugar control or end up in the hospital for hypoglycemia. This trial aims to improve patient safety, health outcomes, and possibly lower healthcare costs.
Interventions
- BEHAVIORAL Proactive population care (active application of HOAP principles in patients flagged as high risk for hypoglycemia)
- BEHAVIORAL Usual care, after system-side dissemination of HOAP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-07-20 |
| Est. Completion | 2024-12-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06746714
The ClinicalTrials.gov registry entry for NCT06746714 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Proactive population care (active application of HOAP principles in patients flagged as high risk for hypoglycemia) is the first listed.
NCT06746714 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06746714 about?
NCT06746714 is a clinical study titled "Hypoglycemia Prevention in High-Risk Type 2 Diabetes Patients". Severe low blood sugar (hypoglycemia) is a serious problem for people with diabetes. It can lead to dangerous falls, heart problems, memory issues, and even death. However, many healthcare providers don't recognize or manage this problem well. The investigators believe that creating a clear set of g...
What is the current status of trial NCT06746714?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2023-07-20. Estimated completion is 2024-12-20.
What interventions are being tested in trial NCT06746714?
The interventions under investigation include: Proactive population care (active application of HOAP principles in patients flagged as high risk for hypoglycemia) (BEHAVIORAL), Usual care, after system-side dissemination of HOAP (BEHAVIORAL).
Who is sponsoring clinical trial NCT06746714?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.